Skip to content

About
Technology
Contact
FR

Nanomedicine nanoparticules features

By glycovax | November 6, 2017 | 0

Nanomedicine nanoparticules features

Leave a Comment Cancel Reply

You must be logged in to post a comment.

Search

Recent Posts

Glycovax Pharma commercializes an outstanding CRM197
Glycovax Pharma Joins Forces with NRC and Université de Montréal to Combat Pseudomonas aeruginosa
Glycovax Pharma launches a highly performant SLA Adjuvant
Glycovax Pharma develops a vaccine to fight Pa-related infections

Recent Comments

Archives

March 2025
February 2025

Categories

News
Press releases

Meta

Log in
Entries feed
Comments feed
WordPress.org

Contact us

info@glycovax.com

info@glycovax.com

1 450 688-7760

424, Guy street, suite 202 Montréal (Quebec) Canada H3J 1S6

Headquarters
424, Guy street, suite 202
Montréal (Quebec) Canada H3J 1S6

500, Cartier boulevard, suite 115 Laval (Quebec) Canada H7V 5B7

Laboratories
500, Cartier boulevard, suite 115
Laval (Quebec) Canada H7V 5B7

Resources

About Glycovax Pharma

Facebook Glycovax LinkedIn Glycovax Pharma

About Glycovax

Glycovax Pharma develops innovative carbohydrate-based vaccines to address critical health needs. We aim to deliver safe and effective solutions to empower vaccine developers as well as protect communities worldwide by fostering scientific excellence, collaboration and leveraging cutting-edge technology.

© 2025 Glycovax Pharma. All Rights Reserved.